Dr. Heather E. Stefanski, MD, PhD, is a leading authority in pediatric hematology, stem cell transplantation, and cell therapy innovation. As Executive Vice President of CIBMTR and Clinical Services at the National Marrow Donor Program (NMDP), she drives national and global initiatives focused on donor safety, transplant access, and cellular therapy advancement. With over 65 peer-reviewed publications and multiple patents, Dr. Stefanski blends clinical excellence with groundbreaking research to improve outcomes for patients worldwide. She serves in key leadership roles across the WMDA, ASH, and ASTCT, and is recognized for her visionary contributions to donor health and translational medicine.

I'm a biotech executive and scientist with a passion for advancing oncology therapeutics from discovery through clinical development. Over the course of my career, I’ve led R\&D strategy and operations in organizations ranging from early-stage startups to large global pharma, including Takeda, ImmunoGen, Novartis, and Biogen. I’ve had the privilege of building high-performing teams, guiding complex portfolios, and contributing to therapies that make a real difference for patients. Today, I enjoy advising innovative biotech companies and VCs as they shape the next generation of cancer treatments.

After more than 30 years immersed in the world of cell and gene therapy, I've had the privilege to lead, innovate, and mentor across academic, clinical, and industry landscapes. From cleanroom design to regulatory submissions and teaching future leaders, my journey has been defined by purpose and progress. Here is my biography.

After 25+ years working at the intersection of science and strategy in cell and gene therapy, I’m excited to share a comprehensive look into my professional journey—from hands-on scientific innovation to leadership across CDMOs, biotech, and academic institutions. My passion lies in building high-impact teams, developing therapies that matter, and bridging ideas to execution. Here is my biography.

Dave Flaten is a seasoned senior executive with a proven track record in building and scaling biotech start-ups, particularly in the medical device and cell therapy sectors. With expertise in strategic planning, product commercialization, and team leadership, he has successfully led global organizations through transformative growth, driving market share and profitability. Flaten’s leadership at Terumo BCT and Ventana Medical Systems showcases his ability to integrate new business units, manage complex global sales organizations, and expand market presence across diverse regions. His strategic vision, operational excellence, and commitment to fostering high-performing teams have made him a key figure in the biotech and healthcare industries, consistently achieving impressive revenue growth and long-term success.